Depression Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

By Drug Class (Atypical Antipsychotics, Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Selective Serotonin Reuptake Inhibitors (SSRIs), Central Nervous System (CNS) Stimulants, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, others), By Disorder Type (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, others), By Drug Type (Generic Drugs, Branded Drugs), By region, and Competition, 2019-2029F

Published	Pages	Publisher	Report code
Apr 2024	182	TechSci Research	ASDR-663307

Published: Apr 2024 - Pages : 182 - Publisher : TechSci Research - Report code : ASDR-663307

1. Otsuka Holdings Co. Ltd.

2. Pfizer Inc.

3. Eli Lilly and Company

4. AstraZeneca plc.

5. Novartis AG

6. Bristol-Myers Squibb Company

7. GlaxoSmithKline plc.

8. Takeda Pharmaceutical Co. Ltd.

9. AbbVie Inc.

10. Johnson & Johnson

Anxiety Disorders and Depression Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

This report can be of interest as well:

Anxiety Disorders and Depression Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019...

Published: February, 2024 | Report code: ASDR-657581